Skip to content
PHARMASEAL logo — An Innovative Clinical Trial Management System for Unified T...

PHARMASEAL

An Innovative Clinical Trial Management System for Unified Trial Governance used by Biopharma, Med Device & CRO's.

Founded 2016 United Kingdom Nottingham, United Kingdom 11 employees Equity Crowdfunding Total: $2.10M Biopharma, Health Care +1

General Information

Company Name PHARMASEAL
Founded Year 2016
Location United Kingdom Nottingham, United Kingdom
Employees 11
Industries Biopharma, Health Care, Pharmaceutical
Funding Stage Equity Crowdfunding

BounceWatch is an independent company data service, not affiliated with PHARMASEAL. To contact PHARMASEAL, visit pharmaseal.co.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PHARMASEAL compare?

A PDF of PHARMASEAL and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PHARMASEAL soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PHARMASEAL

PHARMASEAL is an innovative startup in the pharmaceutical industry, offering a Clinical Trial Management System (CTMS) called Engility. Founded in 2016 in the United Kingdom, the company's mission is to create smarter technologies and innovative products for the improvement of human health. Their flagship product, Engility CTMS, simplifies the management and control of clinical trials for biopharmaceutical and medical device companies. It leverages advanced engineering, offering enterprise management with rapid deployment, an intuitive user interface, and interoperability with other eClinical applications to optimize trial governance and oversight.

The startup recently secured a £500.00K Equity Crowdfunding investment on 24 September 2020. This investment will support PHARMASEAL in further developing and enhancing its CTMS while expanding its reach within the biopharmaceutical, medical device, and Contract Research Organization (CRO) sectors. With a focus on unified trial governance and the backing of industry leaders, PHARMASEAL is well-positioned to make significant contributions to the advancement of clinical trials and, ultimately, human health.

Business keywords: Clinical Trial Management System, Biopharmaceutical, Medical Device, eClinical Technology, eTMF, Enterprise Management, Trial Governance, CTMS, Innovative Products, Agile Software Development, Trial Oversight, Investigator Payments, Site Management, Good Clinical Practice

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Equity Crowdfunding £500.00K -
24 Sep 2020
Series A £1.00M 2
Midlands Engine Investment Fund, Mercia Fund Managers
03 May 2019
Seed Round £500.00K 1
Mercia Fund Managers
23 Jan 2018
Non Equity Assistance Undisclosed 1
Pitch@Palace
25 Apr 2017
Pre Seed Round £100.00K -
10 Oct 2016

PHARMASEAL Alternatives & Competitors

View All Alternatives
PHARMASEAL vs

Navigate To Excellence

322 employees
Health Care, Pharmaceutical
PHARMASEAL vs
Datacapt
Datacapt France

Your Clinical Research. Better. Smarter, faster clinical data management for modern trials.

Pre-Seed
23 employees
Data Analytics, Digital Health
PHARMASEAL vs

Elligo Health Research accelerates clinical trials through EHR data, our proprietary IntElligo® tech...

Debt Financing
316 employees
Biotechnology, Health Care

FAQ About PHARMASEAL

An Innovative Clinical Trial Management System for Unified Trial Governance used by Biopharma, Med Device & CRO's.
PHARMASEAL was founded in 2016.
PHARMASEAL is headquartered in Nottingham, United Kingdom.
PHARMASEAL operates in Biopharma, Health Care and Pharmaceutical. Its work centres on Clinical Trial Management System, Biopharmaceutical, Medical Device and eClinical Technology.
PHARMASEAL has approximately 11 employees.
PHARMASEAL has completed 5 funding rounds, raising a total of $2.10M. The latest funding stage is Equity Crowdfunding.
Top alternatives and competitors to PHARMASEAL include Techsol Life Sciences, Datacapt, Elligo Health Research, Beihai Biotech, Minerva Neurosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PHARMASEAL and Techsol Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PHARMASEAL, https://bouncewatch.com/company/pharmaseal, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout